Literature DB >> 7541722

Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes.

D I Baruch1, B L Pasloske, H B Singh, X Bi, X C Ma, M Feldman, T F Taraschi, R J Howard.   

Abstract

Plasmodium falciparum-infected human erythrocytes evade host immunity by expression of a cell-surface variant antigen and receptors for adherence to endothelial cells. These properties have been ascribed to P. falciparum erythrocyte membrane protein 1 (PfEMP1), an antigenically diverse malarial protein of 200-350 kDa on the surface of parasitized erythrocytes (PEs). We describe the cloning of two related PfEMP1 genes from the Malayan Camp (MC) parasite strain. Antibodies generated against recombinant protein fragments of the genes were specific for MC strain PfEMP1 protein. These antibodies reacted only with the surface of MC strain PEs and blocked adherence of these cells to CD36 but without effect on adherence to thrombospondin. Multiple forms of the PfEMP1 gene are apparent in MC parasites. The molecular basis for antigenic variation in malaria and adherence of infected erythrocytes to host cells can now be pursued.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7541722     DOI: 10.1016/0092-8674(95)90054-3

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  379 in total

1.  Selection for high and low virulence in the malaria parasite Plasmodium chabaudi.

Authors:  M J Mackinnon; A F Read
Journal:  Proc Biol Sci       Date:  1999-04-07       Impact factor: 5.349

2.  Small variant STEVOR antigen is uniquely located within Maurer's clefts in Plasmodium falciparum-infected red blood cells.

Authors:  M Kaviratne; S M Khan; W Jarra; P R Preiser
Journal:  Eukaryot Cell       Date:  2002-12

3.  The adhesion of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A is mediated by P. falciparum erythrocyte membrane protein 1.

Authors:  J C Reeder; A F Cowman; K M Davern; J G Beeson; J K Thompson; S J Rogerson; G V Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Antibodies to Plasmodium falciparum rifin proteins are associated with rapid parasite clearance and asymptomatic infections.

Authors:  Mohamed S Abdel-Latif; Klaus Dietz; Saadou Issifou; Peter G Kremsner; Mo-Quen Klinkert
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

5.  Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.

Authors:  Gerardo Cabrera; Clarisse Yone; Anne E Tebo; Jan van Aaken; Bertrand Lell; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Variable var transition rates underlie antigenic variation in malaria.

Authors:  Paul Horrocks; Robert Pinches; Zóe Christodoulou; Sue A Kyes; Chris I Newbold
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

7.  Comparative analysis of apicomplexa and genomic diversity in eukaryotes.

Authors:  Thomas J Templeton; Lakshminarayan M Iyer; Vivek Anantharaman; Shinichiro Enomoto; Juan E Abrahante; G M Subramanian; Stephen L Hoffman; Mitchell S Abrahamsen; L Aravind
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

8.  Can mutation and selection explain virulence in human P. falciparum infections?

Authors:  Ian M Hastings; S Paget-McNicol; A Saul
Journal:  Malar J       Date:  2004-03-02       Impact factor: 2.979

9.  Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study.

Authors:  Mirjam Kaestli; Ian A Cockburn; Alfred Cortés; Kay Baea; J Alexandra Rowe; Hans-Peter Beck
Journal:  J Infect Dis       Date:  2006-04-20       Impact factor: 5.226

10.  Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.

Authors:  V Amani; M I Boubou; S Pied; M Marussig; D Walliker; D Mazier; L Rénia
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.